LGALS3 and type 2 diabetes mellitus: This is particularly relevant in T2D, where Galectin-3 levels show strong associations with HbA1c, systemic inflammation (e.g., hsCRP) and LV mass, highlighting its potential as a mechanistic link between metabolic dysfunction and myocardial fibrosis [46,65,79,81,85,86].